Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.

Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ.

Nature. 2011 Mar 31;471(7340):597-601. doi: 10.1038/nature09797.

2.

Dopamine in motivational control: rewarding, aversive, and alerting.

Bromberg-Martin ES, Matsumoto M, Hikosaka O.

Neuron. 2010 Dec 9;68(5):815-34. doi: 10.1016/j.neuron.2010.11.022. Review.

3.

Nicotine and endogenous opioids: neurochemical and pharmacological evidence.

Hadjiconstantinou M, Neff NH.

Neuropharmacology. 2011 Jun;60(7-8):1209-20. doi: 10.1016/j.neuropharm.2010.11.010. Review.

PMID:
21108953
4.

Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells.

Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M.

Neuropsychopharmacology. 2011 Feb;36(3):589-602. doi: 10.1038/npp.2010.190.

5.

Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area.

Gao M, Jin Y, Yang K, Zhang D, Lukas RJ, Wu J.

J Neurosci. 2010 Oct 13;30(41):13814-25. doi: 10.1523/JNEUROSCI.1943-10.2010.

6.

Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivity.

Novak G, Seeman P, Le Foll B.

Int J Neurosci. 2010 Nov;120(11):691-7. doi: 10.3109/00207454.2010.513462.

PMID:
20942582
7.

Tobacco dependence, the insular cortex and the hypocretin connection.

Kenny PJ.

Pharmacol Biochem Behav. 2011 Feb;97(4):700-7. doi: 10.1016/j.pbb.2010.08.015. Review.

8.

Differential region-specific regulation of α4β2* nAChRs by self-administered and non-contingent nicotine in C57BL/6J mice.

Metaxas A, Bailey A, Barbano MF, Galeote L, Maldonado R, Kitchen I.

Addict Biol. 2010 Oct;15(4):464-79. doi: 10.1111/j.1369-1600.2010.00246.x.

PMID:
20731631
9.

Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.

Bruijnzeel AW, Bishnoi M, van Tuijl IA, Keijzers KF, Yavarovich KR, Pasek TM, Ford J, Alexander JC, Yamada H.

Psychopharmacology (Berl). 2010 Dec;212(4):485-99. doi: 10.1007/s00213-010-1970-0.

10.

Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression.

Winter C, Vollmayr B, Djodari-Irani A, Klein J, Sartorius A.

Behav Brain Res. 2011 Jan 1;216(1):463-5. doi: 10.1016/j.bbr.2010.07.034.

PMID:
20678526
11.

Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction.

Hogle JM, Kaye JT, Curtin JJ.

Biol Psychiatry. 2010 Oct 15;68(8):719-25. doi: 10.1016/j.biopsych.2010.06.003.

12.

Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.

Drenan RM, Grady SR, Steele AD, McKinney S, Patzlaff NE, McIntosh JM, Marks MJ, Miwa JM, Lester HA.

J Neurosci. 2010 Jul 21;30(29):9877-89. doi: 10.1523/JNEUROSCI.2056-10.2010.

14.

The habenula: from stress evasion to value-based decision-making.

Hikosaka O.

Nat Rev Neurosci. 2010 Jul;11(7):503-13. doi: 10.1038/nrn2866. Review.

15.

Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.

Rezvani AH, Slade S, Wells C, Petro A, Lumeng L, Li TK, Xiao Y, Brown ML, Paige MA, McDowell BE, Rose JE, Kellar KJ, Levin ED.

Psychopharmacology (Berl). 2010 Aug;211(2):161-74. doi: 10.1007/s00213-010-1878-8.

16.

BOLD Responses to Negative Reward Prediction Errors in Human Habenula.

Salas R, Baldwin P, de Biasi M, Montague PR.

Front Hum Neurosci. 2010 May 11;4:36. doi: 10.3389/fnhum.2010.00036.

17.

Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors.

Maskos U.

J Neurochem. 2010 Aug;114(3):641-6. doi: 10.1111/j.1471-4159.2010.06798.x. Review.

18.

Dopamine signals for reward value and risk: basic and recent data.

Schultz W.

Behav Brain Funct. 2010 Apr 23;6:24. doi: 10.1186/1744-9081-6-24. Review.

19.

Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.

Berrendero F, Robledo P, Trigo JM, Martín-García E, Maldonado R.

Neurosci Biobehav Rev. 2010 Nov;35(2):220-31. doi: 10.1016/j.neubiorev.2010.02.006. Review.

20.

Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory.

Ikemoto S.

Neurosci Biobehav Rev. 2010 Nov;35(2):129-50. doi: 10.1016/j.neubiorev.2010.02.001. Review.

Items per page

Supplemental Content

Support Center